OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Metabolic Vulnerabilities and Epigenetic Dysregulation in Myeloproliferative Neoplasms
Vasundhara Sharma, Kenneth L. Wright, Pearlie K. Epling‐Burnette, et al.
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 8
Vasundhara Sharma, Kenneth L. Wright, Pearlie K. Epling‐Burnette, et al.
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 8
Showing 8 citing articles:
Current Approaches to Epigenetic Therapy
Ekaterina D. Griazeva, Д. М. Федосеева, Elizaveta I. Radion, et al.
Epigenomes (2023) Vol. 7, Iss. 4, pp. 23-23
Open Access | Times Cited: 7
Ekaterina D. Griazeva, Д. М. Федосеева, Elizaveta I. Radion, et al.
Epigenomes (2023) Vol. 7, Iss. 4, pp. 23-23
Open Access | Times Cited: 7
Deepening Our Understanding of the Factors Affecting Landscape of Myeloproliferative Neoplasms: What Do We Know about Them?
María Luz Morales, Francisca Ferrer‐Marín
Cancers (2023) Vol. 15, Iss. 4, pp. 1348-1348
Open Access | Times Cited: 5
María Luz Morales, Francisca Ferrer‐Marín
Cancers (2023) Vol. 15, Iss. 4, pp. 1348-1348
Open Access | Times Cited: 5
HDAC11 mediates the ubiquitin-dependent degradation of p53 and inhibits the anti-leukemia effect of PD0166285
Ziwei Zhou, Liang Zhong, Xuan Chu, et al.
Medical Oncology (2023) Vol. 40, Iss. 11
Closed Access | Times Cited: 4
Ziwei Zhou, Liang Zhong, Xuan Chu, et al.
Medical Oncology (2023) Vol. 40, Iss. 11
Closed Access | Times Cited: 4
Mitochondria and Their Relationship with Common Genetic Abnormalities in Hematologic Malignancies
Ibolya Czegle, Austin L. Gray, Minjing Wang, et al.
Life (2021) Vol. 11, Iss. 12, pp. 1351-1351
Open Access | Times Cited: 5
Ibolya Czegle, Austin L. Gray, Minjing Wang, et al.
Life (2021) Vol. 11, Iss. 12, pp. 1351-1351
Open Access | Times Cited: 5
Overview of dyslipidemia and metabolic syndrome in myeloproliferative neoplasms
Mihnea‐Alexandru Găman, Bahadar S. Srichawla, Yongfeng Chen, et al.
World Journal of Clinical Oncology (2024) Vol. 15, Iss. 6, pp. 717-729
Open Access
Mihnea‐Alexandru Găman, Bahadar S. Srichawla, Yongfeng Chen, et al.
World Journal of Clinical Oncology (2024) Vol. 15, Iss. 6, pp. 717-729
Open Access
Spatial-transcriptomic profiling: a new lens for understanding myelofibrosis pathophysiology
Edoardo Peroni, Elisabetta Calistri, Rosario Amato, et al.
Cell Communication and Signaling (2024) Vol. 22, Iss. 1
Open Access
Edoardo Peroni, Elisabetta Calistri, Rosario Amato, et al.
Cell Communication and Signaling (2024) Vol. 22, Iss. 1
Open Access
Current Approaches and Clinical Implications of Epigenetic Modifications in Cancer Therapy
Kukatla Tejesh, Lovish Dhingra, Vinima Gambhir, et al.
Deleted Journal (2024) Vol. 3, pp. 535-535
Closed Access
Kukatla Tejesh, Lovish Dhingra, Vinima Gambhir, et al.
Deleted Journal (2024) Vol. 3, pp. 535-535
Closed Access
Metabolic Biomarkers Affecting Cell Proliferation and Prognosis in Polycythemia Vera
Ziqing Wang, Yan Lv, Erpeng Yang, et al.
Cancers (2022) Vol. 14, Iss. 19, pp. 4913-4913
Open Access | Times Cited: 1
Ziqing Wang, Yan Lv, Erpeng Yang, et al.
Cancers (2022) Vol. 14, Iss. 19, pp. 4913-4913
Open Access | Times Cited: 1
